Opendata, web and dolomites

SERAS_v4.0 SIGNED

Seizure Risk Asessment for Epilepsy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SERAS_v4.0 project word cloud

Explore the words cloud of the SERAS_v4.0 project. It provides you a very rough idea of what is the project "SERAS_v4.0" about.

suffer    treatments    electroencephalogram    mjn    usa    neurological    social    live    quality    mobile    accident    sme    invasive    environment    people    caused    accidents    patients    pathologies    frequency    patient    cloud    platform    knowing    alerts    turnover    reads    discrete    seizures    services    signals    containing    life    intelligence    plan    consists    moved    device    vision    solution    commercialization    65    care    ph2    prediction    create    predicting    neuroserveis    time    validated    benchmark    permanent    disruptive    everybody    worldwide    million    intensity    epilepsy    medical    continuous    diseases    source    digital    serious    accelerate    market    monitors    seizure    monitor    doctors    world    business    recorded    generation    automate    clinically    data    health    global    instrument    occurs    brain    2025    monitoring    depending    suffered    seras    earpiece    portable    permanently    functionalities    reports    wearable    epileptic    minute    27    algorithm    suffers    predicts    claim    artificial    learning    connected   

Project "SERAS_v4.0" data sheet

The following table provides information about the project.

Coordinator
MJN NEUROSERVEIS SL 

Organization address
address: AVENUE JOAN CARLES 184 PLANTA BJS PUERTA DR
city: BLANES
postcode: 17300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 2˙568˙300 €
 EC max contribution 1˙797˙810 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2021-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MJN NEUROSERVEIS SL ES (BLANES) coordinator 1˙797˙810.00

Map

 Project objective

MJN Neuroserveis’ has developed SERAS, a non-invasive, discrete and wearable device that predicts an epileptic seizure before it occurs. The device consists of an earpiece that reads the electroencephalogram, and a cloud-connected mobile application containing an artificial intelligence algorithm that alerts the user, their environment, and medical services one minute before a seizure occurs. In addition, the device permanently monitors a patient's brain activity, allowing for the generation of medical reports, the number of seizures suffered, their intensity and frequency. Currently, doctors who care for these patients do not have the data to allow for targeted patient treatments. Today, there is no device clinically validated in the market with these functionalities that can permanently monitor brain activity in a discrete, portable and continuous way. Around 50-65 million people suffers from epilepsy worldwide, depending on source. These people live in a permanent state of uncertainty, caused by not knowing when they will suffer the next seizure and if it could cause a serious accident for them. SERAS is a disruptive solution unique in monitoring brain signals and predicting epilepsy seizures with enough time to avoid accidents. MJN is a business moved by high social impact vision; our claim is ‘Quality of life for everybody’. We face a market of 6 million epileptic people in EU and USA. We aim to become a new benchmark on a global scale in the digital health world related with neurological diseases. SME Instrument Ph2 project will help us to improve our prediction algorithm in order to automate learning process and create a platform to exploit data recorded from users of the device. This will allow us and doctors go a step further on research of neurological pathologies. By Ph2 project we will accelerate our commercialization plan to scale-up our business to the goal of €27 million turnover by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SERAS_V4.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SERAS_V4.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

ARON (2020)

Assay-Ready Organ Network

Read More  

TalentVision (2019)

INSIGHTS FOR TALENT ASSESSMENT USING COMPUTER VISION TECHNIQUES FROM NEURO PSYCHOLOGY

Read More